SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Paint The Table
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jorj X Mckie who wrote (7966)1/2/2002 3:29:32 PM
From: Libbyt  Read Replies (1) of 23786
 
does it make sense that generic pharms would be a stronger sector?

That's a hard question to answer, since IMO it depends on several factors...the physician prescribing the drug, the patient's financial ability to pay for a drug that is a "name brand" and not a generic drug, and the health insurance or HMO, and what they will cover for specific drugs.

Medical insurance, HMOs, PPOs all seem to have different requirements for the various treatments, and prescription coverage they will allow. What is covered by one insurance policy may not be covered by another policy.

In general, IMO most insurance plans would want to save money and cover only generic drugs when possible, but they would be fighting the physicians in some cases based on the specific drug.

Your question is "something to think about"...I'll ask a couple of people I know who might have better insight
and better answers to your question.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News